LANJIAN(SH:688557)2025-04-29 08:00Financial Performance - The company's revenue for Q1 2025 reached ¥177,281,127.53, representing a 147.09% increase compared to ¥71,748,898.94 in the same period last year[4]. - Net profit attributable to shareholders was ¥1,644,942.52, a significant recovery from a loss of ¥10,837,428.95 in the previous year[4]. - Basic and diluted earnings per share improved to ¥0.02 from -¥0.11 in the same period last year[4]. - The company reported a comprehensive income total of ¥1,669,086.86 for Q1 2025, compared to a loss of ¥10,854,546.97 in Q1 2024[20]. - In Q1 2025, the company reported a net profit of ¥1,027,111.85, a significant improvement compared to a net loss of ¥5,249,851.02 in Q1 2024[29]. Cash Flow and Investments - The net cash flow from operating activities was -¥10,865,862.42, an improvement from -¥45,695,720.78 year-on-year[4]. - Cash flow from operating activities for Q1 2025 was ¥252,557,911.31, an increase from ¥150,682,611.69 in Q1 2024[22]. - The company reported a total of ¥626,146,476.44 in cash inflows from investing activities, a substantial rise from ¥150,325,813.93 in the previous period[24]. - The net cash flow from investing activities was ¥36,146,476.44, compared to ¥42,714,739.63 in the previous period, indicating a decrease[24]. - The cash and cash equivalents at the end of Q1 2025 totaled ¥210,488,756.74, up from ¥135,701,805.65 at the end of Q1 2024, reflecting an increase of approximately 55.2%[32]. Research and Development - Research and development (R&D) expenses totaled ¥33,249,709.23, up 35.73% from ¥24,497,483.11 in the previous year, accounting for 18.76% of revenue[4][5]. - Research and development expenses increased to ¥33,249,709.23 in Q1 2025, compared to ¥24,497,483.11 in Q1 2024, reflecting a growth of 36%[19]. - Research and development expenses for Q1 2025 were ¥25,096,510.98, up from ¥17,896,738.55 in Q1 2024, representing an increase of 40.3%[28]. Assets and Liabilities - Total assets decreased by 3.11% to ¥1,891,210,652.29 from ¥1,951,840,194.13 at the end of the previous year[5]. - Total current assets as of March 31, 2025, amount to ¥1,384,396,039.15, a decrease from ¥1,468,800,257.35 as of December 31, 2024[13][15]. - Total liabilities as of March 31, 2025, are ¥690,255,565.05, down from ¥750,352,169.32[15]. - The total liabilities decreased from ¥783,191,676.41 to ¥720,893,047.71, indicating a reduction of approximately 8%[16]. - The company's total assets decreased from ¥1,951,840,194.13 to ¥1,891,210,652.29, a decline of about 3%[16]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,885[10]. - The largest shareholder, Wu Yaohua, holds 36,497,874 shares, representing 35.71% of total shares[10]. - The company has no significant changes in the participation of major shareholders in margin trading and securities lending[11]. Operational Highlights - The significant increase in revenue was attributed to higher project deliveries in sectors such as construction machinery, chemicals, pharmaceuticals, printing, and new energy vehicles[8]. - The company plans to continue expanding its R&D efforts and improve cash flow management to support future growth[8]. - There are no other significant reminders regarding the company's operational situation during the reporting period[12].